Price to Book Value Chart

View Price to Book Value for CLPBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2012. Start Trial.
Date Value
August 25, 2026 8.003
August 24, 2026 7.981
August 21, 2026 7.584
August 20, 2026 7.496
August 19, 2026 7.694
August 18, 2026 7.485
August 17, 2026 7.253
August 14, 2026 7.363
August 13, 2026 7.396
August 12, 2026 7.363
August 11, 2026 7.544
August 10, 2026 7.330
August 07, 2026 7.496
August 06, 2026 7.286
August 05, 2026 7.385
August 04, 2026 7.408
August 03, 2026 7.496
July 31, 2026 7.385
July 30, 2026 7.452
July 29, 2026 7.363
July 28, 2026 7.330
July 27, 2026 7.132
July 24, 2026 6.823
July 23, 2026 6.658
July 22, 2026 6.878
Date Value
July 21, 2026 6.978
July 20, 2026 7.088
July 17, 2026 7.110
July 16, 2026 7.033
July 15, 2026 6.922
July 14, 2026 6.713
July 13, 2026 6.834
July 10, 2026 6.746
July 09, 2026 6.735
July 08, 2026 6.691
July 07, 2026 6.867
July 06, 2026 6.713
July 02, 2026 6.658
July 01, 2026 6.360
June 30, 2026 6.283
June 29, 2026 6.578
June 26, 2026 6.726
June 25, 2026 6.555
June 24, 2026 6.589
June 23, 2026 6.487
June 22, 2026 6.498
June 18, 2026 6.544
June 17, 2026 6.566
June 16, 2026 6.737
June 15, 2026 6.737

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Ambu A/S 3.604
Abbott Laboratories 3.899
AngioDynamics, Inc. 3.813
Alphatec Holdings, Inc. --
AtriCure, Inc. 4.680

Price to Book Value Related Metrics